Rehmann Capital Advisory Group’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
$637 Buy
+56
New +$637 ﹤0.01% 1611